Mepartricin significantly improves pelvic pain and quality of life compared with the results in placebo group after two months of treatment.[1] Regarding to the theory that hormonal disorders could promote prostatic inflammation,[3] mepartricin, that can lower estrogen levels in prostate, is effective drug in the treatment of patients with chronic pelvic pain syndrome [4] and is referred in 2015 World Journal Pharmacology Updates on therapies for chronic prostatitis/chronic pelvic pain syndrome.